MTOR and nasopharyngeal carcinoma: To confirm whether activation of the PTEN/AKT/mTOR signalling pathway is required for the EMT induction activity of EpCAM in NPC cells, EpCAM-expressing 6–10B cells were treated with MK2206 or rapamycin.